Share on StockTwits

Medtronic (NYSE:MDT) declared a quarterly dividend on Friday, February 14th, Analyst Ratings reports. Investors of record on Friday, April 4th will be given a dividend of 0.28 per share on Friday, April 25th. This represents a $1.12 dividend on an annualized basis and a yield of 1.97%. The ex-dividend date of this dividend is Wednesday, April 2nd.

A number of analysts have recently weighed in on MDT shares. Analysts at Barclays raised their price target on shares of Medtronic from $62.00 to $64.00 in a research note on Thursday, January 9th. They now have an “equal weight” rating on the stock. On the ratings front, analysts at BTIG Research initiated coverage on shares of Medtronic in a research note on Tuesday, January 7th. They set a “neutral” rating on the stock. Finally, analysts at Credit Suisse raised their price target on shares of Medtronic from $62.00 to $64.00 in a research note on Monday, January 6th. Ten analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and an average target price of $61.06.

Medtronic (NYSE:MDT) traded up 0.49% during mid-day trading on Friday, hitting $56.88. The stock had a trading volume of 5,170,488 shares. Medtronic has a 1-year low of $43.51 and a 1-year high of $60.93. The stock has a 50-day moving average of $57.59 and a 200-day moving average of $55.96. The company has a market cap of $56.786 billion and a P/E ratio of 15.13.

Medtronic (NYSE:MDT) last posted its quarterly earnings results on Tuesday, November 19th. The company reported $0.91 earnings per share for the quarter, beating the analysts’ consensus estimate of $0.90 by $0.01. The company had revenue of $4.20 billion for the quarter, compared to the consensus estimate of $4.18 billion. During the same quarter last year, the company posted $0.88 earnings per share. Medtronic’s revenue was up 2.4% compared to the same quarter last year. Analysts expect that Medtronic will post $3.83 EPS for the current fiscal year.

Medtronic, Inc (NYSE:MDT) is engaged in medical technology – alleviating pain, restoring health, and extending life for millions of people worldwide.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.